Table of Contents

Articles

• Articles

  Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice

  Emma Jones, Michaela Dahm-Vicker, Anna Katharina Simon, Angharad Green, Fiona Powrie, Vincenzo Cerundolo and Awen Gallimore

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  CD40 triggering increases the efficiency of dendritic cells for antitumoral immunization

  Naïma Mazouz, Annie Ooms, Véronique Moulin, Sonja Van Meirvenne, Catherine Uyttenhove and Gérard Degiovanni

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins

  Tadao Asai, Walter J. Storkus, Jan Mueller-Berghaus, William Knapp, Albert B. DeLeo, Kazuaki Chikamatsu and Theresa L. Whiteside

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Immunization against a dominant tumor antigen abrogates immunogenicity of the tumor

  Amira Makki, Gunnar Weidt, Nathalie E. Blachere, Leo Lefrançois and Pramod K. Srivastava

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum

  Dirk Jäger, Marc Unkelbach, Claudia Frei, Florian Bert, Matthew J. Scanlan, Elke Jäger, Lloyd J. Old, Yao-Tseng Chen and Alexander Knuth

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  T-cell response to unique and shared antigens and vaccination of cancer patients

  Giorgio Parmiani, Marialuisa Sensi, Chiara Castelli, Licia Rivoltini and Andrea Anichini

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition

  Valérie Dutoit, Philippe Guillaume, Pedro Romero, Jean-Charles Cerottini and Danila Valmori

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: Unexpected reactivity to a protein paralogue

  Roopa Srinivasan, Alan N. Houghton and Jedd D. Wolchok

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma

  Nathalie Vigneron, Annie Ooms, Sandra Morel, Gérard Degiovanni and Benoît J. Van den Eynde

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Urine antibody against human cancer antigen NY-ESO-1

  Dirk Jäger, Elisabeth Stockert, Julia Karbach, Kristina Herrlinger, Akin Atmaca, Michael Arand, Yao-Tseng Chen, Sacha Gnjatic, Lloyd J. Old, Alexander Knuth and Elke Jäger

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Expression of cancer-testis genes in human hepatocellular carcinomas

  Guorong Luo, Shaoming Huang, Xiaoxun Xie, Elisabeth Stockert, Yao-Tseng Chen, Boris Kubuschok and Michael Pfreundschuh

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51

  Elke Jäger, Julia Karbach, Sacha Gnjatic, Dirk Jäger, Markus Maeurer, Akin Atmaca, Michael Arand, Jonathan Skipper, Elisabeth Stockert, Yao-Tseng Chen, Lloyd J. Old and Alexander Knuth

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871

  Zhanqi Liu, Fook-Thean Lee, Nobuo Hanai, Fiona E. Smyth, Antony W. Burgess, Lloyd J. Old and Andrew M. Scott

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Characterization of cells prepared by dendritic cell-tumor cell fusion

  Eva Gottfried, René Krieg, Christian Eichelberg, Reinhard Andreesen, Andreas Mackensen and Stefan W. Krause

  Cancer Immun January 1 2002 2 (1)

  
  
• Articles

  Naturally formed or artificially reconstituted non-covalent alpha2-macroglobulin-peptide complexes elicit CD91-dependent cellular immunity

  Robert J. Binder, Sumeet K. Kumar and Pramod K. Srivastava

  Cancer Immun January 1 2002 2 (1)